Nephrotoxicity from contrast media: attenuation with theophylline.
D000241:Adenosine / Q000037:antagonists & inhibitors / Q000502:physiology / Q000652:urine; D000367:Age Factors; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010919:Placebos; D058915:Purinergic P1 Receptor Antagonists; D016032:Randomized Controlled Trials as Topic; D013806:Theophylline / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D003287:Contrast Media; D010726:Phosphodiesterase Inhibitors; D010919:Placebos; D058915:Purinergic P1 Receptor Antagonists; D013806:Theophylline; D000241:Adenosine